The association of PASI scores with CRH-R1 expression in patients with psoriasis

Archives of Dermatological Research

Volumn 304, Issue 2, 2012, Pages 127-132

  Cemil, Bengü Çevirgen ^a   Canpolat, Filiz ^a   Yılmazer, Demet ^a   Eskioğlu, Fatma ^a   Alper, Murat ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CRH; Psoriasis vulgaris; Receptor; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; EPIDERMIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MENTAL STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS AREA SEVERITY INDEX; PSORIASIS VULGARIS; SCORING SYSTEM; SKIN BIOPSY;

EID: 84857905676     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1218-4     Document Type: Article

References (29)

1. Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R (2006) Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126:1697-1704 (Pubitemid 44086503)
2. Arbiser JL, Karalis K, Viswanathan A et al (1999) Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol 113:838-842
3. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, Lee KF (2002) Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 99:7734-7739 (Pubitemid 34568760)
4. Buske-Kirschbaum A, Kern S, Ebrecht M, Hellhammer DH (2007) Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav Immun 21:92-99 (Pubitemid 44854446)
5. Cao J, Papadopoulou N, Kempuraj D et al (2005) Human mast cells express corticotrophin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174:7665-7675 (Pubitemid 40806271)
6. Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression cloning of a human corticotropin-releasing factor 2 receptor. Proc Natl Acad Sci USA 90:8967-8971 (Pubitemid 23306432)
7. Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244-1252
8. Devrimci-Özgüven H, Kundakçi N, Kumbasar H, Boyvat A (2000) The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 14:267-271 (Pubitemid 32898918)
9. Fredriksson T, Pettersson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238-244 (Pubitemid 8387357)
10. Kim JE, Park HJ (2011) Stress hormone and skin disease. In: Khopkar U (ed) Skin biopsy - perspectives. InTech, pp 209-224
11. Kim JE, Cho DH, Kim HS et al (2007) Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis. Exp Dermatol 16:104-109 (Pubitemid 46040487)
12. Kishimoto T, Pearse RV 2nd, Lin CR, Rosenfeld MG (1995) A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112
13. Kono M, Nagata H, Umemura S, Kawana S, Yoshiki Osamura R (2001) In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 15:2297-2299
14. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, de Souza EB (1996) Cloning and characterization of the human corticotropin releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77
15. O'Kane M, Murphy EP, Kirby B (2006) The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol 15:143-153
16. Perrin MH, Vale WW (1999) Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885:312-328
17. Picardi A, Mazzotti E, Gaetano P et al (2005) Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychomatics 46:556-564 (Pubitemid 41572177)
18. Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J (2001) Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim 37:50-54 (Pubitemid 32245954)
19. Singh LK, Boucher W, Pang X et al (1999) Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 288:1349-1356 (Pubitemid 29254177)
20. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J (2004) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145:941-950 (Pubitemid 38183838)
21. Slominski A, Wortsman J, Luger T et al (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020 (Pubitemid 30452009)
22. Slominski AT, Botchkarev V, Choudhry M et al (1999) Cutaneous expression of CRH and CRH-R: is there a 'skin stress response system?'. Ann NY Acad Sci 885:287-311
23. Slominski AT, Roloff B, Zbytek B et al (2000) Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim 36:211-216 (Pubitemid 30193770)
24. Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K (1984) Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 59:861-866 (Pubitemid 14020685)
25. Tagen M, Stiles L, Kalogeromitros D et al (2007) Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol 127:1789-1791 (Pubitemid 46933407)
26. Theoharides TC, Singh LK, Boucher W et al (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413 (Pubitemid 28166335)
27. Zbytek B, Mysliwski A, Slominski A et al (2002) Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci 70:1013-1021 (Pubitemid 34085093)
28. Zbytek B, Pikula M, Slominski RM et al (2005) Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol 152:474-480 (Pubitemid 40547121)
29. Zhou C, Yu X, Cai D, Liu C, Li C (2009) Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis. Med Hypotheses 73:513-515